What Is Infertility?

Infertility is a disease of the male or female reproductive system defined by the failure to achieve a clinical pregnancy after twelve months or more of regular unprotected intercourse. The interval is shortened to six months when the female partner is 35 or older, because age-related decline in oocyte quantity and quality makes earlier evaluation worthwhile. The condition is classified as primary when no pregnancy has ever been achieved and secondary when it follows a previous pregnancy, and it is diagnosed at the level of the couple rather than the individual, since conception depends on both partners. The World Health Organization fact sheet on infertility estimates that roughly one in six adults worldwide experience infertility at some point in their reproductive lives.

Causes distribute roughly evenly between partners. Female-factor causes account for about a third of cases and include ovulatory disorders such as polycystic ovary syndrome, tubal occlusion following pelvic infection, endometriosis, and uterine structural abnormalities. Male-factor causes account for a comparable share and center on defects of sperm production, transport, or function, with varicocele, genetic conditions, endocrine disorders, and obstructive lesions among the identifiable contributors. A further portion of cases involve contributions from both partners, and in a substantial minority no cause is identified after complete evaluation, which is designated unexplained infertility.

Diagnostic Evaluation

Evaluation follows a defined sequence that tests each requirement for conception in turn. Semen analysis measures concentration, motility, and morphology against reference values and is the first-line male assessment because it is inexpensive and noninvasive. Ovulation is confirmed by mid-luteal serum progesterone, basal body temperature charting, or urinary luteinizing hormone testing, and ovarian reserve is estimated from anti-Mullerian hormone level and antral follicle count on transvaginal ultrasound. Tubal patency is assessed by hysterosalpingography, which uses radiographic or ultrasound contrast to demonstrate flow through the fallopian tubes, or by laparoscopy with chromopertubation when direct visualization is warranted. The NICHD overview of infertility and fertility summarizes this workup and the treatment decisions that follow from it.

Assisted Reproductive Technology

Treatment escalates from ovulation induction with clomiphene citrate, letrozole, or gonadotropins, through intrauterine insemination, to assisted reproductive technology. In vitro fertilization is the dominant technique: ovaries are stimulated with gonadotropins, oocytes are retrieved under ultrasound guidance, fertilization occurs in the laboratory, and one or more resulting embryos are transferred to the uterus. Intracytoplasmic sperm injection, in which a single spermatozoon is injected directly into an oocyte with a micromanipulator, addresses severe male-factor cases. The NICHD summary of assisted reproductive technology describes the procedures and the reporting requirements that make outcomes traceable. Supporting technologies include time-lapse incubator imaging for embryo selection, vitrification for oocyte and embryo cryopreservation, and preimplantation genetic testing for aneuploidy and monogenic disease.

Engineering Contributions

Reproductive medicine draws heavily on instrumentation and computation. Microfluidic devices sort motile sperm without the centrifugation that damages membranes, and computer-assisted sperm analysis replaces subjective microscopy with automated motility tracking. Machine learning models trained on time-lapse embryo image sequences predict implantation potential, and closed-loop incubator control maintains temperature, pH, and oxygen tension within narrow tolerances. Wearable and home monitoring devices that estimate the fertile window from basal temperature, heart rate, and hormone metabolites extend measurement outside the clinic.

Applications

Research and technology development around infertility spans several fields, including:

• Medical imaging, including transvaginal and contrast-enhanced ultrasound
• Microfluidics and lab-on-a-chip gamete handling
• Machine learning for embryo selection and outcome prediction
• Cryobiology and controlled-rate freezing systems
• Point-of-care and home hormone assay development
• Public health surveillance and registry data analysis